These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7150356)

  • 1. Effects of haloperidol and apomorphine on catecholamine metabolism in brain slices. Reserpine-like effects of haloperidol.
    Delanoy RL; Dunn AJ
    Biochem Pharmacol; 1982 Oct; 31(20):3297-305. PubMed ID: 7150356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
    Dismukes K; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine metabolism in brain slices. Determination of relevant precursor pool and the effects of elevated K+.
    Delanoy RL; Hunter GD; Dunn AJ
    Biochem Pharmacol; 1982 Oct; 31(20):3289-96. PubMed ID: 6816242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?
    Saner A; Pletscher A
    Eur J Pharmacol; 1977 Mar; 42(2):155-60. PubMed ID: 844496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a sulfonium analog of dopamine on the depolarization-induced release of [3H]acetylcholine from mouse striatal slices.
    Turowski B; Szkrybalo M; Anderson K; Miller D; Uretsky N
    Biochem Pharmacol; 1984 Aug; 33(15):2371-6. PubMed ID: 6466358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTH 1-24 and lysine vasopressin selectively activate dopamine synthesis in frontal cortex.
    Delanoy RL; Kramarcy NR; Dunn AJ
    Brain Res; 1982 Jan; 231(1):117-29. PubMed ID: 6275944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the effects of apomorphine and haloperidol on the release of [3H]-dopamine and [3H]-noradrenaline from rabbit brain slices.
    Kelly MJ
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):18-29. PubMed ID: 7271378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.
    Reches A; Wagner HR; Jackson-Lewis V; Fahn S
    Brain Res; 1985 Nov; 347(2):346-9. PubMed ID: 3933764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apomorphine, alpha-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cell lines (PC-12 and N1E-115).
    Bräutigam M; Laschinski G; Kittner B; Herken H
    Biochem Pharmacol; 1985 Apr; 34(7):941-7. PubMed ID: 3921032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum.
    Westfall TC; Besson MJ; Giorguieff MF; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(3):279-87. PubMed ID: 181686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity.
    McMillen BA; Shore PA
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):39-44. PubMed ID: 6111026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urapidil on catecholamine turnover and release in the central nervous system of the rat.
    Singer EA; Cichini G; Valenta B; Kraupp O
    J Pharm Pharmacol; 1989 Mar; 41(3):173-8. PubMed ID: 2568444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
    Spampinato U; Girault JA; Danguir J; Savaki HE; Glowinski J; Besson MJ
    Brain Res Bull; 1986 Feb; 16(2):161-6. PubMed ID: 3697784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices.
    Langeveld CH; Schepens E; Stoof JC; Bast A; Drukarch B
    Free Radic Biol Med; 1995 Aug; 19(2):209-17. PubMed ID: 7649492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors.
    Buu NT
    Biochem Pharmacol; 1989 May; 38(10):1685-92. PubMed ID: 2730683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.